Ikarian Capital, LLC Iovance Biotherapeutics, Inc. Put Options Transaction History

Ikarian Capital, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 13, 2022	SELL	$12.38 - $19.1 $2.43 Million - $3.74 Million	-196,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $81,400 - $106,520	-4,000 Reduced 2.0%	196,000 $4.83 Million
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $5.73 Million - $10.5 Million	200,000 New	200,000 $6.33 Million

312

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.